Acorn Capital Advisors, LLC Candel Therapeutics, Inc. Call Options Transaction History
Acorn Capital Advisors, LLC
- $185 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CADL
# of Institutions
71Shares Held
10.7MCall Options Held
750KPut Options Held
469K-
Baker Bros. Advisors LP New York, NY2.98MShares$25.4 Million0.29% of portfolio
-
Northpond Ventures, LLC1.94MShares$16.5 Million48.35% of portfolio
-
Braidwell LP Stamford, CT1.6MShares$13.6 Million0.78% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.34MShares$11.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY823KShares$7.01 Million0.0% of portfolio
About Candel Therapeutics, Inc.
- Ticker CADL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,891,900
- Market Cap $246M
- Description
- Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the...